Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
about
Organ allocation for chronic liver disease: model for end-stage liver disease and beyondModel for End-stage Liver DiseaseIschemia/reperfusion, does temperature matter? Laboratory perspective.Impact of the center on graft failure after liver transplantationRescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'.Variation in organ quality between liver transplant centers.Organ quality and quality of life after liver transplantationDevelopment of organ-specific donor risk indices.Decision support for organ offers in liver transplantation.Model for end-stage liver disease: end of the first decade.Systematic bias in surgeons' predictions of the donor-specific risk of liver transplant graft failure.Prognostic limitations of the Eurotransplant-Donor Risk Index in liver transplantation.Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.Liver transplantation in the high MELD era: a fair chance for everyone?Experience Since MELD Implementation: How Does the New System Deliver?The donor risk index: A decade of experience.D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation.SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVALTransplant for the very sick: No limitations in donor quality?Regional differences in deceased donor liver transplantation and their implications for organ utilization and allocation.Survival benefit of liver transplantation: one size fits all or fits none?Early changes in liver distribution following implementation of Share 35.
P2860
Q24633350-CF1D7634-566B-423E-8C68-C8B464FF41CCQ26864971-3D23E219-E953-4038-8254-2AF199901B98Q30278761-2ECBC3D8-790C-45F3-8050-A9FFA1ACC714Q34034827-0314A687-9A8C-477B-A607-C20BC7CB9376Q34383294-22B745D2-3E36-42FD-9C23-BA2955BC3A9EQ35220446-A3A0CD64-8BC0-447F-96EC-F31C55625672Q35773148-9F5CEC25-EB8C-4820-9465-4ADDCA2DD9B3Q35903771-E3E49D01-A269-4ED2-8C97-B1D044BECB8EQ36554175-FF0B5CD9-EC83-480D-9692-F320A0E6EC9CQ36588122-DCB4B548-100E-4611-BBCB-D61D10643C94Q37179408-4D9DA6E5-6DCC-4458-ABD6-E20FB6409BE9Q37425201-1EB5F83C-DBF2-4896-80C2-62D0DE143004Q37789176-FD4E0075-01F6-4E5A-991D-C77D5876C3C7Q37850723-78B4C603-8F70-44A1-ACDA-666C97FB8C3AQ38054733-CD2C47A6-1406-463D-9308-3D884C3DFCD9Q38738555-EF74C897-0807-4DAA-A2FB-35394B174500Q42183293-33D4CE1D-F323-4C38-B93A-97EC15F052A1Q42809649-5FAF7FEA-5BDE-4C62-89AE-91659F8AA8AAQ43726265-F24493C7-DC20-44BD-AF77-89290D8939BFQ45182302-20CD4C7E-80D9-4522-9C23-C8B867C797CCQ47176019-D72811EC-E135-4211-896B-E5D60B25E048Q50957436-21F5A9F7-0235-403A-8560-D7C24BFD7ED2
P2860
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impact of the model for end-st ...... ans for liver transplantation.
@en
Impact of the model for end-st ...... ans for liver transplantation.
@nl
type
label
Impact of the model for end-st ...... ans for liver transplantation.
@en
Impact of the model for end-st ...... ans for liver transplantation.
@nl
prefLabel
Impact of the model for end-st ...... ans for liver transplantation.
@en
Impact of the model for end-st ...... ans for liver transplantation.
@nl
P2093
P1433
P1476
Impact of the model for end-st ...... ans for liver transplantation.
@en
P2093
Anna S F Lok
Michael L Volk
Peter A Ubel
Rodney A Hayward
Shawn J Pelletier
P304
P356
10.1053/J.GASTRO.2008.08.003
P407
P577
2008-11-01T00:00:00Z